Cirrhosis - Nursing Case Study
Pathophysiology
• Primary mechanism: Chronic liver injury, often due to hepatitis or alcohol, leads to persistent inflammation and hepatocyte necrosis. This triggers activation of hepatic stellate cells, which transform into myofibroblasts, producing excessive extracellular matrix and collagen, resulting in irreversible fibrotic scarring and architectural distortion of liver parenchyma.
• Secondary mechanism: Fibrotic changes disrupt normal hepatic blood flow, causing increased intrahepatic resistance and portal hypertension. This condition leads to the formation of portosystemic shunts, bypassing the liver and diminishing its detoxification capacity.
• Key complication: Portal hypertension contributes to severe complications such as esophageal varices and ascites. Additionally, impaired liver function and shunting can lead to toxin accumulation, precipitating hepatic encephalopathy, characterized by altered mental status and cognitive dysfunction.
Patient Profile
Demographics:
57-year-old male, retired construction worker
History:
• Key past medical history: Alcoholic liver disease, Hepatitis C infection, Type 2 Diabetes, Hypertension
• Current medications: Furosemide, Spironolactone, Lactulose, Metformin, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing abdominal distension and confusion
• Key symptoms: Jaundice, ascites, peripheral edema, fatigue, confusion, hematemesis
• Vital signs: Blood Pressure 89/56 mmHg, Heart Rate 112 bpm, Respiratory Rate 22 breaths per minute, Temperature 38.3°C, Oxygen Saturation 89% on room air
Section 1
Initial assessment findings reveal a critically deteriorating condition. The patient's abdominal distension is significant, with the presence of a fluid wave indicating severe ascites. His skin and sclera exhibit pronounced jaundice. Neurological examination shows disorientation to time and place, and the patient is unable to perform serial sevens, highlighting cognitive impairment indicative of hepatic encephalopathy. Breath sounds are diminished at the lung bases, likely due to pleural effusion secondary to ascites. The abdomen is tender, and there is evidence of spider angiomas on the upper trunk, a result of hyperestrogenism associated with liver failure.
Laboratory results are concerning. Serum ammonia levels are markedly elevated at 115 µmol/L (normal range 15-45 µmol/L), supporting the diagnosis of hepatic encephalopathy. Liver function tests show severely elevated transaminases, with AST at 220 U/L and ALT at 180 U/L, alongside a bilirubin level of 8.5 mg/dL. Coagulation studies reveal an INR of 2.5, indicating significant coagulopathy due to impaired hepatic synthesis of clotting factors. A complete blood count indicates thrombocytopenia, with a platelet count of 70,000/µL, enhancing the risk for bleeding, particularly concerning given the potential for variceal hemorrhage.
The patient's hemodynamic instability is critical, with hypotension and tachycardia suggesting a hypovolemic state potentially exacerbated by gastrointestinal bleeding or sepsis. The patient is transferred to the intensive care unit for close monitoring and aggressive management. Immediate interventions focus on stabilizing hemodynamics with IV fluid resuscitation and initiating broad-spectrum antibiotics to preempt spontaneous bacterial peritonitis, a known complication of cirrhosis with ascites. These findings and interventions set the stage for the next phase of treatment, where the impending risk of variceal bleeding and worsening encephalopathy must be vigilantly managed.
Section 2
Response to Interventions
In the intensive care unit, the patient's condition remains precarious despite initial interventions. The IV fluid resuscitation has led to a modest improvement in blood pressure, now recorded at 95/60 mmHg, yet the heart rate persists at 110 beats per minute, indicating ongoing compensatory tachycardia. Importantly, urine output has decreased to less than 20 mL/hour, raising concerns for renal hypoperfusion and potential hepatorenal syndrome, a serious complication in advanced cirrhosis.
The administration of broad-spectrum antibiotics to prevent spontaneous bacterial peritonitis is closely monitored, but within 12 hours, the patient develops a fever of 101.2°F, and leukocytes in ascitic fluid analysis suggest a high probability of infection. These findings necessitate a reevaluation of the antibiotic regimen, as the risk of sepsis becomes increasingly imminent. Concurrently, hepatic encephalopathy worsens, with the patient exhibiting asterixis and periods of unresponsiveness, necessitating the initiation of lactulose therapy to reduce serum ammonia levels.
Given the patient's deteriorating mental status and potential for variceal bleeding, the healthcare team decides on an urgent endoscopic evaluation to assess for esophageal varices. This decision is complicated by the severe coagulopathy, requiring careful consideration of prophylactic blood product administration to minimize bleeding risk during the procedure. As the clinical team navigates these complex challenges, they must maintain vigilance for the emergence of acute-on-chronic liver failure, balancing aggressive treatment with the patient's fragile physiological state.
Section 3
As the team proceeds with the endoscopic evaluation, the patient's coagulopathy presents a significant challenge. Pre-procedure lab results reveal a markedly elevated INR of 2.8 and a platelet count of 55,000/µL, necessitating the administration of fresh frozen plasma and platelets to mitigate bleeding risks. Despite these preparations, the procedure reveals large, grade III esophageal varices that pose an imminent threat of hemorrhage. The decision is made to perform prophylactic band ligation to prevent bleeding, a procedure not without risks given the patient's unstable condition.
Post-procedure, the patient's status shows signs of acute deterioration. The heart rate escalates to 130 beats per minute, and blood pressure drops to 85/50 mmHg, suggesting potential variceal bleeding or hemodynamic instability. Repeat labs indicate a hemoglobin level of 7.4 g/dL, a drop from previous measurements, and suggestive of possible bleeding or continued dilutional anemia. The team quickly initiates a transfusion of packed red blood cells, closely monitoring for any signs of transfusion reactions or further decompensation.
The patient's neurological status remains concerning, with persistent hepatic encephalopathy despite lactulose therapy. Serum ammonia levels are now critically elevated at 145 µmol/L. The intensivists consider alternative therapies, including rifaximin, to better manage the encephalopathy. Simultaneously, nephrology is consulted due to worsening renal function; serum creatinine has risen to 2.5 mg/dL, and the diagnosis of hepatorenal syndrome type 1 is entertained. This complex interplay of complications demands a multidisciplinary approach, with the team prioritizing stabilization of the patient's hemodynamic status, optimization of liver and renal function, and prevention of further infectious complications.
Section 4
As the multidisciplinary team continues to address the patient's complex condition, new diagnostic results provide further insight into the challenges at hand. An urgent abdominal ultrasound is conducted to assess for any ascites or portal vein thrombosis that might be contributing to the patient's hemodynamic instability. The ultrasound reveals moderate ascites, which could be exacerbating the patient’s respiratory compromise, and a Doppler study shows diminished flow in the portal vein, raising concerns for portal hypertension and potential thrombotic complications. Given these findings, the team debates the necessity of a paracentesis to alleviate pressure and improve respiratory status, balancing the risk of bleeding due to the patient’s coagulopathy.
Concurrently, a repeat ECG and cardiac enzymes are obtained to rule out cardiac contributions to the patient's tachycardia and hypotension. The ECG does not show acute ischemic changes, but the elevated troponin level of 0.12 ng/mL suggests possible myocardial strain, likely secondary to the patient's compromised hemodynamic state. This necessitates careful fluid management to avoid exacerbating cardiac stress while still addressing the patient's ongoing hypotension.
The team reconvenes to integrate these new findings into the patient's care plan. With the diagnosis of hepatorenal syndrome type 1, the nephrology consult recommends initiating terlipressin and albumin infusions to improve renal perfusion. Gastroenterology suggests transitioning to intravenous antibiotics to preempt potential infections, given the risk of spontaneous bacterial peritonitis secondary to ascites. As the team works to stabilize the patient, they remain vigilant for further complications, such as acute respiratory distress syndrome from fluid overload or worsening encephalopathy, which would require rapid intervention. Through this carefully coordinated approach, the aim is to optimize the patient's condition and prevent progression of the multifaceted challenges presented by cirrhosis and its complications.
Section 5
As the team continues to manage the patient's condition, a sudden change in status prompts immediate re-evaluation. The patient becomes increasingly confused and disoriented, with a significant deterioration in their mental status, suggesting worsening hepatic encephalopathy. Vital signs show a blood pressure of 88/54 mmHg, heart rate of 112 bpm, respiratory rate of 28 breaths per minute, and oxygen saturation dropping to 88% on 4L nasal cannula. Laboratory results reveal a marked elevation in ammonia levels at 95 µmol/L, alongside a bilirubin level climbing to 7.6 mg/dL, indicative of worsening liver function. Arterial blood gases show a pH of 7.32, pCO2 of 52 mmHg, and HCO3 of 18 mmol/L, suggesting a mixed respiratory and metabolic acidosis, likely exacerbated by the ascites-related respiratory compromise.
Recognizing the critical nature of the situation, the team prioritizes interventions to manage the encephalopathy and support respiratory function. Lactulose is administered to reduce ammonia levels, and rifaximin is added to the regimen to target gut bacteria contributing to the condition. Given the patient's respiratory distress, the team decides to escalate oxygen support to high-flow nasal cannula and considers the potential need for non-invasive ventilation if respiratory status does not improve. The nephrology team adjusts the terlipressin and albumin dosing to optimize renal perfusion while cautiously managing fluid balance to prevent further respiratory compromise.
The interdisciplinary team closely monitors for new complications, such as aspiration risk due to altered mental status or further hemodynamic instability. They remain vigilant for signs of spontaneous bacterial peritonitis, particularly given the patient's immunocompromised state. By integrating these new findings and adjustments into the care plan, the team works to stabilize the patient, understanding that the management of cirrhosis with multi-organ involvement requires continuous reassessment and swift, informed clinical decisions.